Advertisement
Advertisement
December 3, 2024
Terumo’s R2P NaviCross Peripheral Support Catheter Launched in United States
December 3, 2024—Terumo Interventional Systems, a division of Terumo Corporation, announced the expansion of the company’s radial-to-peripheral (R2P) portfolio with the launch of its R2P NaviCross peripheral support catheter in the United States.
According to the company, the R2P NaviCross catheter is commercially available in a 200-cm length. It is designed with double-braided, stainless-steel construction, and is engineered for trackability and torque control for lesion crossing in more complex procedures.
Michael J. Martinelli, MD, Chief Medical Officer, Terumo Medical Corporation, discussed the new device in the company’s press release.
“With the 200-cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more procedures from a radial approach,” commented Dr. Martinelli. “Additionally, the double-braided, stainless-steel design of the R2P NaviCross catheter makes it possible to access and cross simple-to-complex lesions above and below the knee.”
Advertisement
Advertisement
